ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

NCI-Approved Trials Listed

March 30, 2007

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002